abrdn Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
abrdn Investment Management's PFE Position: Q2 2017 in Review
abrdn Investment Management increased its Pfizer (PFE) stake by 0.59% in Q2 2017, buying an estimated $1.52M and bringing the position to 8,225,346 shares worth $262M. The position accounts for 0.89% of the portfolio, ranked #37.
abrdn Investment Management first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $355M in Q2 2016. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- abrdn Investment Management held 8,225,346 shares of Pfizer worth $262M as of Q2 2017.
- abrdn Investment Management bought 48,263 Pfizer shares in Q2 2017, an estimated $1.52M.
- Pfizer made up 0.89% of abrdn Investment Management's portfolio in Q2 2017, its #37 holding.
- abrdn Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
- abrdn Investment Management's Pfizer position peaked at $355M in Q2 2016.
- 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.